A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
Clinical trial NCT01323244 · COMPLETED
Trial details
- NCT number
- NCT01323244
- Sponsor
- Janssen R&D Ireland
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-03-01
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.